Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-18-015158

Chief Executive Officer sold 15,000 shares at an average $69.36 ($1,040,400)

  • Chief Executive Officer gave up 741 shares (to pay taxes)
  • Chief Executive Officer acquired 15,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kulkarni Samarth Chief Executive Officer 2018-06-01 Option exercise +15,000 $1.81 $27,150 163,560 D
Kulkarni Samarth Chief Executive Officer 2018-06-01 Sale −4,600 $67.28 $309,488 158,960 D
Kulkarni Samarth Chief Executive Officer 2018-06-01 Sale −10,400 $70.28 $730,912 148,560 D
Kulkarni Samarth Chief Executive Officer 2018-06-04 Shares withheld for taxes −741 $67.13 $49,743 147,819 D
Derivatives
Kulkarni Samarth Chief Executive Officer 2018-06-01 Option exercise · Employee Stock Option (right to buy) −15,000 264,558 D
Open-market sales · 15,000 sh · avg $69.36 · $1,040,400
Loading xslF345X03/doc4.xml…